GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medimi AB (XSAT:MEDIMI) » Definitions » COGS-to-Revenue

Medimi AB (XSAT:MEDIMI) COGS-to-Revenue : 0.57 (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Medimi AB COGS-to-Revenue?

Medimi AB's Cost of Goods Sold for the three months ended in Mar. 2025 was kr0.77 Mil. Its Revenue for the three months ended in Mar. 2025 was kr1.35 Mil.

Medimi AB's COGS to Revenue for the three months ended in Mar. 2025 was 0.57.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medimi AB's Gross Margin % for the three months ended in Mar. 2025 was 42.85%.


Medimi AB COGS-to-Revenue Historical Data

The historical data trend for Medimi AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medimi AB COGS-to-Revenue Chart

Medimi AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.60 1.59 0.73 0.44 0.74

Medimi AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.94 0.53 0.84 0.57

Medimi AB COGS-to-Revenue Calculation

Medimi AB's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.578 / 4.807
=0.74

Medimi AB's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.771 / 1.349
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medimi AB  (XSAT:MEDIMI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medimi AB's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.771 / 1.349
=42.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Medimi AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medimi AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medimi AB Business Description

Traded in Other Exchanges
Address
Zinkgatan 2, Lomma, SWE, 234 35
Medimi AB is engaged in the development, production, and marketing of medication products. It offers Medimi Pro and Medimi Smart computerized pill dispensers that are used by patients, consumers, and healthcare staff to follow their drug schedule. The company focus on the following market segments namely Pharmaceutical industry, Hospital and retirement homes, Home Health Care, Pharmacy and private care, and Connected Health (Telemedicine), E-Health and Integration in Other Systems.

Medimi AB Headlines

No Headlines